Clinical outcomes of reperfusion therapy in patients with site-specific basilar artery occlusion

医学 溶栓 改良兰金量表 病因学 闭塞 置信区间 冲程(发动机) 大脑中动脉 外科 内科学 回顾性队列研究 优势比 心脏病学 缺血 缺血性中风 心肌梗塞 机械工程 工程类
作者
Nina Žakelj,Igor Rigler,Alja Longo,Senta Frol,Janja Pretnar Oblak
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:17 (11): 1249-1253 被引量:3
标识
DOI:10.1136/jnis-2024-022065
摘要

Background Despite its low incidence, basilar artery occlusion (BAO) remains a major therapeutic challenge since severe disability and death occur in about 80% of patients. Specific site of BAO (proximal, middle, or distal) has rarely been reported as a prognostic factor in reperfusion therapy. We aimed to explore the relationship between site-specific BAO and clinical outcomes in patients treated with reperfusion therapies. Methods We performed a single-centre retrospective study of all consecutive patients with acute BAO admitted to the University Medical Centre Ljubljana between January 2013 and August 2022 who were treated with reperfusion therapies. Patients were grouped according to the location of BAO and compared for baseline characteristics, differences in stroke aetiology, type of reperfusion therapy, success of recanalization, and clinical outcome after 90 days evaluated by the modified Rankin Scale (mRS) score. Statistical analysis was performed with the two-sided ANOVA t-tests for continuous measures, Chi-squared (χ2) tests for categorical measures and a multivariate ordinal logistic regression analysis. Results The study included 103 patients (47% females, median age 74 years; confidence interval (CI) 72 to 98). Proximal BAO was found in 13%, middle in 13%, and distal in 74% of patients. Cardioembolic etiology was more common in distal (=0.01), and atherosclerotic etiology in proximal and middle BAO occlusions (P=0.02). While distal BAO was more likely to be recanalized using intravenous thrombolysis (IVT) compared with other sites of occlusion (P=0.05), we found no difference between different occlusion sites and the success of endovascular treatment (EVT). Lower age (odds ratio (OR) 0.89; CI 0.84 to 0.95; P<0.01) and shorter time to intervention (OR 0.71; CI 0.53 to 0.95; P=0.02), regardless of it being IVT or EVT, were predictors of an excellent clinical outcome (mRS 0–2). Distal occlusion (OR 28; CI 2.7 to 300; p<0.01) was a strong predictor of a favorable clinical outcome (mRS 0–3). Conclusion Prompt reperfusion, regardless of it being IVT or EVT, increases the chance of excellent clinical outcomes in patients with acute BAO. Distal BAO is more often associated with a favorable clinical outcome compared with the proximal and middle segments.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
DYIZ完成签到,获得积分10
2秒前
李健的小迷弟应助司空铭采纳,获得10
2秒前
搜集达人应助tigger采纳,获得10
2秒前
smile完成签到 ,获得积分10
3秒前
名不显时心不朽完成签到,获得积分10
4秒前
wy18567337203发布了新的文献求助10
4秒前
DW应助夕沫采纳,获得10
4秒前
领导范儿应助研友_LJGmvn采纳,获得30
4秒前
YUMI发布了新的文献求助20
5秒前
molihuakai应助47采纳,获得10
5秒前
5秒前
zy关闭了zy文献求助
5秒前
nuo关注了科研通微信公众号
5秒前
小蘑菇应助林白采纳,获得50
6秒前
6秒前
6秒前
儒雅天才完成签到,获得积分20
6秒前
7秒前
大模型应助追寻的彩虹采纳,获得10
7秒前
毕业毕业完成签到,获得积分10
7秒前
Tajoyo完成签到,获得积分10
8秒前
无限绮南完成签到,获得积分10
9秒前
万能图书馆应助wy18567337203采纳,获得10
9秒前
nsywhh2完成签到,获得积分10
9秒前
10秒前
upup完成签到,获得积分10
10秒前
科研通AI6.4应助愉快尔曼采纳,获得10
10秒前
汉堡包应助慈祥的丹寒采纳,获得10
11秒前
12秒前
12秒前
12秒前
在水一方应助可爱的凝安采纳,获得10
14秒前
14秒前
14秒前
15秒前
赵雪茹完成签到,获得积分10
15秒前
wy18567337203完成签到,获得积分10
15秒前
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Rosenblum, Global Change Biology 500
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
DIPPR Project 801 - Full Version 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7767598
求助须知:如何正确求助?哪些是违规求助? 9311142
关于积分的说明 20321997
捐赠科研通 7352630
什么是DOI,文献DOI怎么找? 3315412
关于科研通互助平台的介绍 2464705
邀请新用户注册赠送积分活动 2330053